The immunosuppressant, FTY720 causes apoptosis of lymphocytes, reduces numbers of lymphocytes in peripheral blood, and prevents inˆltration of lymphocytes into allografts, which may be one of the mechanisms involved in its eŠects. Here we compared caspase activation and expression of cell-cycle regulators during apoptosis caused by FTY720, and Fas-stimulation in a mouse lymphoma transfected with human Fas antigen. FTY720 activated caspases-3, -8, and -9 as rapidly as did Fas-mediated apoptosis. The activation was blocked by a peptide inhibitor for caspase-3, DEVD-CHO. Fasinduced activation of caspases-8 and -9 was unaŠected by the inhibitor. FTY720 eliminated proliferating cell nuclear antigen, retinoblastoma family members, diŠerentiation regulated transcription factor polypetide-1, and cyclin H. These cell-cycle regulators were not eliminated when the peptide inhibitor was used. Dysfunction of cell-cycle regulators may play a critical role in the signal transduction pathway for activation of FTY720-mediated apoptosis.
2-Amino-2-[2-(4-octylphenyl)ethyl] propane-1,3-diol hydrochloride (FTY720) was synthesized by chemical modiˆcation of a natural immunosuppressant, ISP-1, isolated from the ascomycete Isaria sinclairii, a member of the vegetable wasp and plant worm family. [1] [2] [3] Upon oral administration, FTY720 prolongs survival of transplanted allografts without noticeable toxicity to the host, 1, [4] [5] [6] [7] [8] [9] but the original product, ISP-1, causes severe digestive disorders, resulting in death of the animal. 2, 3) Administration of a single dose of 10 mg W kg FTY720 to healthy rats reduces the number of peripheral lymphocytes, with a minimum by 3 h after the administration; recovery of the lymphocyte counts to pretreatment levels takes 2 weeks. 8) Probably this profound and long-lasting decrease in lymphocytes is the basic mechanism of immunosuppression by FTY720.
Two mechanisms for the decrease in lymphocytes have been proposed. In one, FTY720 sequesters lymphocytes in secondary lymphoid organs where the lymphocytes enter a specialized compartment to await their corresponding antigens or egress from lymph nodes. Administration of FTY720 decreases the number of lymphocytes in the blood and thoracic duct, and increases the number in peripheral lymph nodes, mesenteric lymph nodes, and Peyer's patches. 10, 11) This lymphocyte homing increased by FTY720 is blocked by antibodies against lymphocyte homing receptors, including VD62L and CD49d. In mice infected with lymphocytic choriomeningitis virus, FTY720 shifts the distribution of speciˆc cytotoxic T cells from the spleen to peripheral lymph nodes without aŠecting the induction of speciˆc T or B cells. 12) FTY720 inhibits the inˆltration of lymphocytes into skin grafts in rats, 13) or into the islets of pancreas in a T-cell-mediated model of diabetes. 12) The phosphorylated metabolite of FTY720 has agonistic activity on sphingosine-1-phosphate receptors. 14) These agonists produce lymphopenia in the blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, and lead to emptying of lymphoid sinuses by causing retention of lymphocytes on the abluminal side of endothelium lining sinuses by inhibiting their egress into the lymph.
In the second possible mechanism, FTY720 causes apoptosis of lymphocytes. [15] [16] [17] FTY720 activates caspases-3, -8, and -9, reduces mitochondrial transmembrane potential, and releases cytochrome c from the mitochondria of intact cells and also in a cell-free system. 18, 19) The mitochondrial reactions occur before caspase activation. A caspase inhibitor suppresses apoptosis, but not these mitochondrial responses.
Overexpression of Bcl-2 or inhibitors of mitochondrial transmembrane potential rescue cells from apoptotic death mediated by FTY720. 17, 19) These observations suggest that FTY720 directly aŠects mitochondria and triggers changes in permeability leading to further apoptotic events. FTY720 activates some members of mitogen-activated protein kinases including c-Jun NH2-terminal kinase, p38 W cytokinesuppressant anti-in‰ammatory drug-binding protein, and p36 myelin basic protein kinase. 20) Although extracellular signal-regulated kinases are not activated by FTY720, their activation by 12-O-tetradecanoylphorbol 13-acetate or by transient expression of constitutively active mitogen-activated protein kinase blocks FTY720-induced cell death and blocks the activation of c-Jun NH2-terminal kinase, p38, and p36. Because a caspase inhibitor can block activation of mitogen-activated protein kinases, the activation of the kinases occurs in the downstream signal transduction pathway of caspase activation for apoptosis caused by FTY720.
Caspases involved in apoptosis are generally divided into two categories, initiators and eŠectors. 21) Caspase-3 is a typical eŠector, cleaving intracellular substrates such as PARP; 22) inhibitor of caspase-activated deoxyribonuclease, which inhibits degradation of chromosomes into nucleosomal fragment, mediated by caspase-activated deoxyribonuclease; [23] [24] [25] and Acinus, needed for apoptotic chromatin condensation. 26) The products obtained in turn cause morphological change or DNA fragmentation. Caspase-8 and caspase-9 are initiators that activate eŠector caspases through the speciˆc cleavage of inactive zymogens. 21, [27] [28] [29] Triggering of Fas-antigen results in receptor trimerization and recruitment of Fas-associated death domain to the receptor complex, which in turn binds to caspase-8 and brings about its autoactivation. 30 ) Caspase-9 is a downstream target of mitochondrial activation. In the presence of dATP and cytochrome c, caspase-9 interacts with apoptotic protease activating factor-1, leading to autoactivation, which also activates eŠector caspases. 31) Cell-cycle regulators such as c-Myc 32, 33) and E2F family transcription factors [34] [35] [36] cause chronic apoptosis, so dysfunction of cell-cycle regulation may be involved in this process. Although the roles of such regulators in acute apoptosis of lymphocytes after drug administration and in stimulation of death receptors have not been fully analyzed, evidence suggests their contribution to this process. In acute apoptosis of tumor cells, cdc2 kinase is activated at an inappropriate time during the cell-cycle, and DNA fragmentation and nuclear collapse can be prevented by blocking of the kinase activity. 37) Similar activation of cdc2 kinase and cdk2 kinase associated with cyclin A is involved in granzyme-B-mediated apoptosis. 38) Cyclin B W cdc2 kinase is elevated during the apoptosis of an activated T cell hybridoma, which process is suppressed by cyclin-B-speciˆc antioligonucleotides. 39) In this study, we examined the involvement of cell-cycle regulators in FTY720-mediated acute apoptosis of a mouse lymphoma compared with that mediated by Fas-stimulation, and found that several cell-cycle regulators are eliminated from the apoptotic cells induced by FTY720. Cell-cycle regulators may be involved in FTY720-mediated apoptosis.
Materials and Methods
Cell Culture. A mouse T cell line, WR19L W Fas, established by transfection with a vector expressing human Fas mRNA from a viral promoter, 40) was kindly provided by S. Yonehara (Osaka, Japan). Cell lines were cultured at 379 C in Dalbecco's modiˆed Eagle medium containing 50 mg W ml kanamycin, 8 mg W ml tylosin and 5z fetal bovine serum in a humidied 10z CO 2 atmosphere using. were purchased from Calbiochem. Anti-Fas IgM was from MBL (CH-11, Tokyo, Japan), or from eBioscience (clone EOS9.1). Anti-cyclin A serum from an immunized rabbit was used. Anti-E2F-1 (KH20) and anti-DP-1 (WTH10), puriˆed monoclonal antibodies produced by hybridomas, were kindly provided by Chin-Li Wu (MGH Cancer Center, Charlestown, MA).
DNA Fragmentation Assay. DNA fragmentation as a result of apoptosis was made visible as described previously. 36) One million cells were suspended in 100 ml of lysis buŠer (10 mM Tris, 10 mM EDTA, and 0.5z Triton X-100, pH 7.4). Resultant post-nuclear extracts were treated with 40 mg of RNase A for 60 min at 379 C, and then with 40 mg of proteinase K for 60 min at 379 C. Fragmented DNA was precipitated by the addition of 20 ml of 5 M NaCl and 120 ml of isopropanol. Precipitates were washed with 70z ethanol, dissolved in 20 ml of 10 mM Tris, and 1 mM EDTA (pH 8.0), and run on a 2z agarose gel containing 500 ng W ml ethidium bromide.
Western Blotting. Immunodetection of protein was done as described previously. 41) In brief, cells were lysed in 2×SDS sample buŠer containing 100 mM dithiothreitol, and uniform amounts of each sample were resolved by electrophoresis in SDS denaturing polyacrylamide gels. Proteins in the gel were transferred to Immobilon-P membranes (Millipore). Blots were blocked in 5z nonfat dry milk in 20 mM Tris, 0.8z NaCl, and 0.1z Tween 20 (pH 7.5), probed with a primary antibody, and then with the appropriate secondary antibody coupled with horse radish peroxidase (Amersham). Signals were seen as ‰uorescence emission with use of commercial detection kits (Amersham and Roche Diagnosis) as directed by the instructions of the suppliers.
Assay of Caspase Activity. WR19L W Fas cells (1× 10 6 s W well) were treated with FTY720 or anti-Fas antibody, washed once with Dalbecco's phosphate buŠered saline (Sigma, St. Louis), and suspended in 200 ml of lysis buŠer (10 mM Tris-HCl, pH 7.5, 10 mM NaH 2 PO 4 W Na 2 HPO 4 pH 7.5, 130 mM NaCl, 1z Triton X-100, and 10 mM sodium pyrophosphate) at 49 C for 10 min. The lysate was centrifuged at 20,000×g for 5 min, and the supernatant obtained was assayed. Fifty microliters of the supernatant was incubated with 10 mg W ml DEVD-AMC (caspase-3), IETD-AMC (caspase-8), or LEHD-AMC (caspase-9) at 379 C for 1 h, and the reaction was stopped by the addition of 1 mg W ml DEVD-CHO (caspase-3), IETD-CHO (caspase-8), or LEHD-CHO (caspase-9). The enzyme activities were monitored by spectro‰uoro-metry with 380 nm as the excitation wavelength and 440 nm as the emission wavelength. The enzyme activity was expressed in terms of ‰uorescence intensity.
Cell-Cycle Analysis. One million WR19L W Fas cells were washed with Dalbecco's phosphate buŠered saline once and suspended in 1 ml of staining buŠer (4 mM sodium citrate, pH 6.3, 0.2z NP-40, and 50 mg W ml propidium iodide). Flow cytometry (Epics XL, Coulter) was used to measure the DNA content of individual cells, as described previously. 42) Cell debris and aggregated cells were eliminated through gating on a two-dimensional proˆle, propidium iodide ‰uorescence versus front scattering. The percentage of the population in each phase of the cellcycle was computed by Mac Cycle AV (Phoenix Flow System, San Diego).
Results

Apoptosis of WR19L W Fas Cells Caused by FTY720
Treatment of WR19L W Fas, a mouse lymphoma line that stably expresses human Fas antigen with anti-Fas IgM led to apoptosis within 4 h, and DNA ladders of the nucleosome unit (189 bp) characteristic of apoptotic cells were detected in post-nuclear cell extracts on the agarose gel (Fig. 1) . FTY720 (40 mM, an optimal dose for induction of apoptosis 43) ) caused similar DNA ladders, although the ladders were less intense than with anti-Fas IgM. With FTY720 and anti-Fas IgM, nuclear morphology was apoptotic in 50-60z and 60-80z, respectively, of cells 4 h after their addition, as reported previously. 43) A peptide inhibitor speciˆc for caspase-3, DEVD-CHO, almost completely suppressed the DNA fragmentation caused by FTY720 or by anti-Fas IgM. In contrast, YVAD-CHO, an inhibitor speciˆc for caspase-1, inhibited neither kind of apoptosis, as reported previously. 20) The cleavage of poly(ADP-ribose) polymerase (PARP), a typical substrate for caspase-3, 22) by Western blotting is shown in Fig. 2 . The intact 115-kDa PARP was converted to a 85-kDa cleavage product by treatment with FTY720 or anti-Fas IgM. This cleavage was blocked by DEVD-CHO but not by YVAD-CHO, consistent with the results shown in Fig. 1 . The expression of a-tubulin was only slightly reduced in apoptotic cells induced with either treatment (Fig. 2) . In contrast, proliferating cell nuclear antigen (PCNA) and cyclin A were reduced in cells treated with FTY720, and the reduction was not overridden by the addition of a peptide caspase inhibitor. Cyclin A, but not PCNA, also reduced in cells treated with anti-Fas IgM, and the reduction was blocked by either peptide.
Activation of Caspases by FTY720
Caspase activities in WR19L W Fas cells treated with FTY720 measured are shown in Fig. 3 . FTY720 activated caspases-3, -8, and -9 within 30 min; the activities gradually decreased with further incubation. Because FTY720 damages membranes within 120 min, 43) cytoplasmic caspases might leave the cells 120 min after the addition of FTY720. The activation was inhibited completely by DEVD-CHO and partly by YVAD-CHO. Fas stimulation induced three caspase activities within 30 min, but the activity at this point was lower than that with FTY720. In contrast to apoptosis with FTY720, however, these activities increased for the entire 120 min of incubation, and the activation of caspases-8 and -9 was resistant to the peptide inhibitors that aŠect caspases-1 and -3. Activation of caspase-3 with anti-Fas IgM was inhibited by DEVD-CHO but not by YVAD-CHO, although YVAD-CHO partly suppressed activity for the 120 min after its addition.
Elimination of Cell-Cycle Regulators During FTY720-Induced Apoptosis
The decrease in expression of cyclin A and PCNA seen in cells treated with FTY720 prompted us to examine the expression of other regulators of the cellcycle progression. We found that retinoblastoma (Rb) family proteins also were absent from cells treated with FTY720 (Fig. 4) . Although the expression of E2F-1, the downstream target of pRb, was not aŠected by FTY720, its heterodimeric partner, diŠerentiation regulated transcription factor polypeptide-1(DP-1) was eliminated by FTY720. Of other cyclins D and H, the expression of cyclin H was decreased with FTY720. No marked diŠerence was observed in the expression of c-Myc or two cdks. Treatment with DEVD-CHO did not block these changes in protein expression. The expression of pRb was decreased in cells treated with anti-Fas IgM, and this decrease was almost completely blocked by DEVD-CHO.
The distribution of cells in phases of the cell-cycle, analyzed by ‰ow cytometry during apoptosis induced by FTY720 and Fas-stimulation, is shown in Fig. 5 . FTY720 and anti-Fas IgM aŠected the proˆle of DNA content of intact cells little if at all during 8 h of incubation. DEVD-CHO increased the population of S-phase cells in FTY720-treated cells. Cells in the sub-G1 region were detected 4 h after the addition of FTY720, and this population was not changed by further incubation. On the other hand, this population appeared late at 23 h, after the addition of antiFas IgM, and DNA fragmentation and activation of caspases occurred 4 h after this addition. These results suggest that the population in the sub-G1 region may be disintegrated cells produced during apoptosis.
Discussion
FTY720 induces apoptosis of lymphocytes, and this phenomenon seems to be one of the mechanisms for the prolongation of graft survival and the decrease in the number of lymphocytes in peripheral blood with this compound. 8, 19) DEVD-CHO inhibits activation of caspases-3 and -8 but not that of caspase-9, 18) and ectopic expression of Bcl-2 blocks the activation of caspase-3, -8, and -9, and also blocks apoptosis. These observations suggested that the primary target of FTY720 for apoptosis is mitochondria in Jurkat cells.
In this study, however, we observed that the activation of initiator caspases induced by FTY720 but not by Fas-stimulation depended on the activation of caspase-3. FTY720 activated caspases-3, -8, and -9 with similar kinetic proˆles, and the activations were completely suppressed by a peptide inhibitor of caspase-3, DEVD-CHO. Because caspase-3 can cleave procaspases-8, and -9, converting them to active forms, 27, 29) DEVD-CHO might suppress activation of these initiator caspases by blocking the feedback activation loop through caspase-3. FTY720 may activate initiator caspases at an undetectable level through activating mitochondria. This activation might be increased to a detectable level through positive feedback, as was suggested by a report that staurosporine fails to activate caspase-3 in caspase-9-deˆcient embryonicˆbroblasts, or caspase-9 in caspase-3-deˆcient embryonicˆbroblasts. 44) However, the possibility seems unlikely because DEVD-CHO did not suppress the activation of caspase-8 or -9 in WR19L W Fas cells treated with anti-Fas IgM. In addition, DEVD-CHO does not inhibit activation of caspase-9 in FTY720-treated Jurkat cells. 18) Alternatively, in WR19L W Fas cells, there might be a pathway leading to the activation of caspase-3 other than mitochondria activation. FTY720 might induce apoptosis in WR19L cells by a pathway distinct from that in Jurkat cells or embryonicˆbrob-lasts, because the signal transduction pathway for apoptosis is dependent on the kind of cell rather than on the way apoptosis is induced. 45) We found that the expression of several cell-cycle regulators was reduced during the apoptosis induced by FTY720, and that the reduction was not aŠected by DEVD-CHO. In spite of the changes in the expression of these regulators, the distribution of intact cells in the cell-cycle was aŠected little by the addition of FTY720, suggesting that the cell-cycle proceeds with the dysfunction of cell-cycle regulators in cells treated with FTY720. Cell-cycle progression when such regulators are not functioning normally often induces apoptosis. Our results suggest that the dysfunction of cell-cycle regulators is involved in the pathway leading to the activation of caspase-3.
Among cell-cycle regulators we found to be aŠect-ed by FTY720, pRb was reduced most. pRb protects cells from apoptosis. Radiation-induced apoptosis of human osteosarcoma lacking pRb is suppressed by wild-type pRb but not by a mutant pRb, that fails to complex with several binding partners including E1A and E2F. 46) We earlier observed that the DNA-binding pRb W E2F-1 complex increased in Chinese hamster cells expressing human E2F-1; cells later died through apoptosis. 36) These observations suggest that several proteins that induce apoptosis such as E1A, E2F-1 and c-Myc, may do so by interfering with the protective function of pRb. FTY720 may lead to apoptosis through the elimination of pRb, which protects cells from apoptosis.
In cells treated with FTY720, membrane damage precedes nuclear damage, but membrane damage is followed by nuclear damage in Fas-stimulated apoptosis. 43) DEVD-CHO completely suppresses the nuclear damage induced by both apoptosis inducers. Experiments done with enucleated cytoplasts also show that the membrane damage induced by FTY720 but not by anti-Fas antibody is blocked by the inhibitor. Because exogenous sphingolipids partially suppress FTY720-induced membrane damage, modulation of the sphingoid pathway by FTY720 is involved in induction of membrane damage. 32) Like the induction of membrane damage, the elimination of cell-cycle regulators was resistant to DEVD-CHO.
